Healthcare Services

Global Vaccine Technologies Market Analysis for 2026–2030 with Strategic Forecast Insights for Businesses

April 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Vaccine Technologies Market During 2026–2030?

The vaccine technologies market has experienced substantial growth in recent years. Looking ahead, it is projected to expand from $61.38 billion in 2025 to $67.71 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.3%. The historical growth of this market stemmed from various factors, including the expansion of national immunization initiatives, increased public health funding, advancements in vaccine production technologies, growth in infectious disease surveillance, and the establishment of global vaccine supply chains.

The vaccine technologies market size is anticipated to demonstrate significant expansion over the coming years. It is predicted to reach $99.04 billion by 2030, registering a compound annual growth rate (CAGR) of 10.0%. This projected growth can be ascribed to several factors, including increasing investments in next-generation vaccine platforms, a rising demand for pandemic preparedness solutions, the broadening of adult vaccination programs, a growing focus on vaccines for non-infectious diseases, and the increasing adoption of digital systems for tracking vaccines. Prominent trends expected in this forecast period involve the accelerating development of mRNA and recombinant vaccines, a heightened focus on rapid vaccine manufacturing platforms, the expanding adoption of novel delivery technologies, the extension of global immunization programs, and an enhanced emphasis on cold chain optimization.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24735&type=smp

Which Economic Or Industry Drivers Are Impacting The Vaccine Technologies Market?

The expanding occurrence of infectious diseases is anticipated to drive the advancement of the vaccine technologies market in the future. These diseases are conditions resulting from detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can be transmitted between individuals through direct or indirect contact. The growing incidence of infectious diseases stems from enhanced global travel, allowing pathogens to disseminate quickly across different regions. Vaccine technologies assist in the management of infectious diseases by initiating specific immune reactions, thereby contributing to the prevention and control of infections. These technologies bolster public health initiatives by diminishing the dissemination and intensity of diseases, leading to better overall healthcare results. For example, in February 2024, the UK Health Security Agency stated that tuberculosis, a contagious bacterial infection primarily affecting the lungs, saw its cases in England rise to 4,850 in 2023, up 10.7% from 4,380 cases in 2022. Consequently, the expanding occurrence of infectious diseases is a key factor propelling the advancement of the vaccine technologies market.

How Are The Various Segments Of The Vaccine Technologies Market Categorized?

The vaccine technologies market covered in this report is segmented –

1) By Type: Recombinant Or Conjugate Or Subunit, Inactivated, Live Attenuated, Toxoid

2) By Route Of Administration: Parenteral, Oral, Nasal

3) By Disease Indication: Infectious Diseases, Non-Infectious Diseases

4) By Age Group: Pediatric, Adults

5) By Distribution Channel: Hospital And Retail Pharmacies, Government Suppliers, Other Distribution Channels

Subsegments:

1) By Recombinant Or Conjugate Or Subunit: Protein Subunit Vaccines, Virus-Like Particle (VLP) Vaccines, Glycoconjugate Vaccines, Recombinant Vector Vaccines

2) By Inactivated: Whole-Virus Inactivated Vaccines, Split-Virus Inactivated Vaccines, Purified Inactivated Vaccines

3) By Live Attenuated: Viral Live Attenuated Vaccines, Bacterial Live Attenuated Vaccines

4) By Toxoid: Diphtheria Toxoid Vaccines, Tetanus Toxoid Vaccines

How Are Trends Shaping The Direction Of The Vaccine Technologies Market?

Major companies operating in the vaccine technologies market are increasingly focused on developing advanced solutions, such as quadrivalent influenza vaccines, to ensure wider immunization coverage and minimize the potential for strain mismatch. Quadrivalent influenza vaccines are formulations designed to safeguard against four influenza virus strains, specifically two influenza A and two influenza B viruses, thereby providing more comprehensive protection than trivalent vaccines. For example, in February 2025, Zydus Lifesciences, an India-based pharmaceutical company, launched VaxiFlu-4, which is a quadrivalent influenza vaccine. This vaccine offers seasonal protection against four influenza strains, covering both influenza A and B types, and is administered as a single-dose intramuscular injection, suitable for both adults and children. It plays a role in reducing the impact of seasonal influenza by offering broader strain coverage compared to traditional trivalent vaccines.

Which Major Firms Influence Developments In The Vaccine Technologies Market?

Major companies operating in the vaccine technologies market are Pfizer Inc, Johnson And Johnson, Merck And Co Inc, Sanofi SA, AstraZeneca Plc, GSK Plc, Moderna Inc, CSL Limited, Bharat Biotech International Limited, Bavarian Nordic AS, Takeda Pharmaceutical Company Limited, Sinovac Biotech Ltd, Emergent BioSolutions Inc, Valneva SE, Novavax Inc, Dynavax Technologies Corporation, CureVac NV, Inovio Pharmaceuticals Inc, Serum Institute Of India Pvt Ltd, BioNTech SE, Panacea Biotec Ltd, Biological E Limited

Read the full vaccine technologies market report here:

https://www.thebusinessresearchcompany.com/report/vaccine-technologies-global-market-report

What Are The Top-Performing Regions Within The Vaccine Technologies Market?

North America was the largest region in the vaccine technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaccine technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Vaccine Technologies Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24735&type=smp

Browse Through More Reports Similar to the Global Vaccine Technologies Market 2026, By The Business Research Company

Swine Vaccines Global Market Report

https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report

Typhoid Vi Polysaccharide Vaccine Global Market Report

https://www.thebusinessresearchcompany.com/report/typhoid-vi-polysaccharide-vaccine-global-market-report

Dog Vaccines Global Market Report

https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795